The only randomized controlled trial of wormwood in joint disease used a topical 3% preparation applied to the skin[1], not an oral supplement. Oral wormwood carries thujone-related seizure risk and is contraindicated in pregnancy, in seizure disorders, and alongside anticonvulsant medication. Do not substitute wormwood for a prescribed arthritis treatment without talking to your clinician.
- One randomized, double-blind trial in 90 patients with knee osteoarthritis compared a topical 3% Artemisia absinthium ointment against piroxicam gel, a standard topical NSAID[1]
- The ointment improved pain and physical function comparably to piroxicam gel, but did not significantly improve joint stiffness; the liniment form performed noticeably worse than the ointment[1]
- A separate human pilot study found oral thujone-free wormwood lowered proteinuria in a TNF-α-driven kidney condition, which is the mechanistic reason the joint question was worth asking at all[2]
- Lab work shows wormwood extract inhibits lipoxygenase at a potency in the same range as ibuprofen in that specific assay — an in vitro finding, not a clinical result[3]
- The rheumatoid arthritis trial people often cite used Artemisia annua (sweet wormwood), a different species with different chemistry[4]
Wormwood shows up in traditional European rub-on remedies for aching joints, and unlike most herbal joint claims, this one has actually been put through a randomized double-blind trial. The result is more interesting than either the enthusiasts or the skeptics usually admit: it worked, in one specific form, for one specific set of outcomes, applied to the skin. This article walks through exactly what was tested and where the evidence stops.
The One Randomized Trial: Topical Wormwood vs. Piroxicam Gel
Researchers at Hamadan University of Medical Sciences in Iran enrolled 90 outpatients aged 30 to 70 with diagnosed primary osteoarthritis in at least one knee. Patients were randomly assigned to three groups of 30 and treated three times daily for four weeks[1]:
- Wormwood ointment 3% (a thicker, fat-based topical preparation)
- Wormwood liniment 3% (a thinner, more liquid topical preparation)
- Piroxicam gel — the active comparator, a conventional topical NSAID
Outcomes were measured with a 10-point visual analog scale for pain plus the WOMAC index, the standard osteoarthritis instrument covering pain, physical function, and stiffness. Patients were assessed at baseline, at week 4 (end of treatment), and again at week 6, two weeks after stopping — which is the part that makes this trial genuinely informative.
What the results actually showed
The three arms did not perform the same way[1]:
- Piroxicam gel significantly improved every measured outcome, with no recurrence after the treatment protocol was stopped.
- Wormwood ointment improved pain, total pain score, and physical function to a degree the authors described as comparable to piroxicam — but it did not significantly improve the stiffness score.
- Wormwood liniment only reduced the pain measures, and only at week 4. By week 6 the benefit had reverted.
The authors’ conclusion was appropriately narrow: wormwood ointment may have beneficial effects in osteoarthritis. Not wormwood generally, not wormwood capsules, and not the liniment. The formulation was the variable that decided whether it worked, which is a detail almost every secondary write-up of this study drops.
Why a Rub-On Herb Would Do Anything at All
Two threads of research explain why this was a reasonable thing to test rather than a lucky hit.
The first is TNF-α. A pilot study in ten patients with early-stage IgA nephropathy gave 1.8 g/day of a thujone-free wormwood preparation for six months on top of existing medication, on the rationale that wormwood can lower TNF-α, an inflammatory signaling protein. Urine protein-to-creatinine ratio fell from roughly 2,340 to 315 mg/g and stayed down through six months of follow-up after the supplement was stopped[2]. That study was small, uncontrolled, and about kidneys rather than joints — it proves nothing about arthritis. What it does establish is that wormwood’s anti-inflammatory effect is measurable in living people, not just in a dish.
The second is the enzyme work. In a 2023 analysis, a concentrated Artemisia absinthium extract inhibited lipoxygenase with an IC50 of 19.71 µg/mL, essentially matching ibuprofen’s 20.19 µg/mL in the same assay[3]. Lipoxygenase drives the leukotriene arm of the inflammatory cascade. This is an in vitro comparison under laboratory conditions and does not mean a wormwood product is as strong as ibuprofen in a person — but it identifies a plausible mechanism for a topical anti-inflammatory effect.
The Rheumatoid Arthritis Study Is a Different Plant
Search for wormwood and arthritis and you will quickly hit a much larger, more impressive trial: 159 patients with active rheumatoid arthritis, randomized, 48 weeks, where adding the herbal extract to methotrexate and leflunomide beat the drugs alone on tender joints, swollen joints, CRP, rheumatoid factor, and quality of life, with fewer adverse effects[4].
That trial used Artemisia annua — sweet wormwood, the artemisinin plant used in malaria treatment. It is a different species from Artemisia absinthium, with a different active compound profile, and products sold as “wormwood” are usually one or the other, not interchangeably both. Applying the rheumatoid arthritis result to an A. absinthium capsule is a species substitution, not an evidence-based inference. If that finding is what interests you, the plant to research is sweet wormwood.
What This Does Not Tell Us
- Nothing about oral wormwood for joint pain. The osteoarthritis trial was topical. No trial has tested oral A. absinthium for arthritis at any dose.
- Nothing about long-term use. The treatment period was four weeks with a two-week follow-up. Osteoarthritis is a decades-long condition.
- Nothing replicated. This is a single trial from a single center. A finding that has not been independently reproduced is a lead, not a conclusion.
- Nothing about retail products. The trial used a 3% preparation made to a research specification. Shelf wormwood salves are not standardized to that, and most do not state a percentage at all.
If You Are Considering It Anyway
The realistic reading of this evidence is that a topical wormwood preparation is a low-risk thing to try alongside — not instead of — whatever is actually managing your osteoarthritis, and that it is likelier to touch pain and function than stiffness. Topical application also sidesteps the thujone problem that governs oral wormwood dosing, since systemic absorption through skin is minimal compared with swallowing an extract.
Oral wormwood is a different risk calculation entirely. Thujone is neurotoxic at sufficient doses, oral wormwood is contraindicated in pregnancy and in anyone with a seizure disorder, and it interacts with anticonvulsant medication. Notably, the one human study that used oral wormwood safely for six months used a thujone-free preparation[2] — which is not what most shelf products are.
FAQ
Does wormwood help arthritis?
One randomized double-blind trial found a topical 3% wormwood ointment improved knee osteoarthritis pain and physical function comparably to piroxicam gel over four weeks, though it did not significantly improve stiffness[1]. That is a single unreplicated trial of a topical preparation.
Can I take wormwood capsules for joint pain?
No trial has tested oral wormwood for joint pain. The osteoarthritis evidence is entirely topical, and oral wormwood carries thujone-related seizure risk that a skin application does not.
Is wormwood as strong as ibuprofen?
In one laboratory enzyme assay, wormwood extract inhibited lipoxygenase at a concentration close to ibuprofen’s[3]. That is a test-tube comparison of one enzyme and does not translate to equivalent pain relief in a person.
What about the rheumatoid arthritis study?
That trial used Artemisia annua (sweet wormwood), a different species from Artemisia absinthium[4]. The results do not transfer between the two plants.
Ointment or liniment?
In the trial, the ointment outperformed the liniment. The liniment only reduced pain at week 4, and the effect reverted by week 6[1].
References
- Basiri Z, Zeraati F, Esna-Ashari F, et al. Topical Effects of Artemisia Absinthium Ointment and Liniment in Comparison with Piroxicam Gel in Patients with Knee Joint Osteoarthritis: A Randomized Double-Blind Controlled Trial. Iranian Journal of Medical Sciences. 2017;42(6):524-531. pubmed.ncbi.nlm.nih.gov/29184260/…
- Krebs S, Omer B, Omer TN, Fliser D. Wormwood (Artemisia absinthium) for poorly responsive early-stage IgA nephropathy: a pilot uncontrolled trial. American Journal of Kidney Diseases. 2010;56(6):1095-1099. pubmed.ncbi.nlm.nih.gov/20843592/…
- Neagu E, Paun G, Albu C, et al. In Vitro Assessment of the Antidiabetic and Anti-Inflammatory Potential of Artemisia absinthium, Artemisia vulgaris and Trigonella foenum-graecum Extracts Processed Using Membrane Technologies. Molecules. 2023;28(20):7156. pubmed.ncbi.nlm.nih.gov/37894635/…
- Yang M, Guo MY, Luo Y, et al. Effect of Artemisia annua extract on treating active rheumatoid arthritis: A randomized controlled trial. Chinese Journal of Integrative Medicine. 2017;23(7):496-503. pubmed.ncbi.nlm.nih.gov/28035541/…
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
